Tibet Duo Rui Pharmaceutical
301075
ChengDu Sheng Nuo Biotec
688117
Nanjing Railway New Technology
301016
4
Shenzhen Jasic Technology
300193
5
THEC
833509
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 29, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 24, 2023 | (Q2)Jun 25, 2023 | (Q1)Mar 26, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 27.01%83.17M | 27.01%83.17M | -33.25%89.71M | 7.48%52.86M | 4.67%35.13M | -35.28%65.49M | -35.28%65.49M | -53.40%134.39M | -60.63%49.18M | -32.83%33.56M |
-Cash and cash equivalents | 27.01%83.17M | 27.01%83.17M | -33.25%89.71M | 7.48%52.86M | 4.67%35.13M | -35.28%65.49M | -35.28%65.49M | -53.40%134.39M | -60.63%49.18M | -32.83%33.56M |
Receivables | 107.34%164.86M | 107.34%164.86M | 128.49%201.65M | 14.57%114.55M | 10.31%61.53M | 12.11%79.51M | 12.11%79.51M | 13.37%88.26M | -3.84%99.99M | -59.78%55.78M |
-Accounts receivable | 107.34%164.86M | 107.34%164.86M | 128.49%201.65M | 14.57%114.55M | 13.14%61.53M | 12.11%79.51M | 12.11%79.51M | 13.37%88.26M | -1.44%99.99M | -11.50%54.39M |
-Taxes receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -98.20%1.39M |
Inventory | 73.22%71.1M | 73.22%71.1M | 63.55%89.84M | -6.64%61.48M | -1.61%55.88M | -9.38%41.05M | -9.38%41.05M | 10.60%54.93M | 16.33%65.85M | 44.62%56.79M |
Prepaid assets | 292.55%19.33M | 292.55%19.33M | ---- | -42.74%11.98M | 5.73%10.5M | -60.82%4.93M | -60.82%4.93M | --2.27M | --20.92M | --9.93M |
Other current assets | 243.66%61.4M | 243.66%61.4M | 197.64%75.76M | 14.56%30.52M | -3.38%27.16M | 29.68%17.87M | 29.68%17.87M | 10.44%25.45M | -33.83%26.64M | -23.34%28.11M |
Total current assets | 91.47%399.87M | 91.47%399.87M | 49.67%456.96M | 3.36%271.39M | 3.27%190.19M | -14.33%208.84M | -14.33%208.84M | -30.45%305.31M | -44.88%262.58M | -30.39%184.16M |
Non current assets | ||||||||||
Net PPE | 163.57%4.52B | 163.57%4.52B | 207.03%5.22B | 1.60%1.76B | 2.94%1.76B | 2.46%1.72B | 2.46%1.72B | 2.42%1.7B | 7.34%1.74B | -2.92%1.71B |
-Gross PPE | 74.87%7.14B | 74.87%7.14B | 92.11%7.76B | 3.68%4.17B | 4.43%4.13B | 4.48%4.09B | 4.48%4.09B | 4.30%4.04B | 6.39%4.02B | 1.62%3.95B |
-Accumulated depreciation | -10.59%-2.62B | -10.59%-2.62B | -8.76%-2.55B | -5.26%-2.41B | -5.56%-2.37B | -6.00%-2.37B | -6.00%-2.37B | -5.71%-2.34B | -5.67%-2.29B | -5.38%-2.24B |
Goodwill and other intangible assets | 1,237.12%4.19B | 1,237.12%4.19B | 1,079.35%3.68B | -0.88%311.17M | 0.32%311.98M | 0.49%313.69M | 0.49%313.69M | 0.12%312.44M | -0.55%313.95M | -2.30%310.98M |
-Goodwill | 1,145.73%3.3B | 1,145.73%3.3B | 957.12%2.79B | -0.81%262.59M | 0.35%263.18M | 0.54%264.63M | 0.54%264.63M | 0.18%263.56M | -0.47%264.74M | -2.18%262.27M |
-Other intangible assets | 1,730.00%897.83M | 1,730.00%897.83M | 1,738.39%898.66M | -1.27%48.58M | 0.18%48.8M | 0.23%49.06M | 0.23%49.06M | -0.20%48.88M | -1.00%49.21M | -2.95%48.71M |
Other non current assets | 703.33%12.05M | 703.33%12.05M | 441.39%12.19M | -69.14%1.06M | -69.13%1.26M | -67.79%1.5M | -67.79%1.5M | -54.37%2.25M | -52.13%3.44M | -24.95%4.07M |
Total non current assets | 329.72%8.73B | 329.72%8.73B | 342.67%8.91B | 1.10%2.08B | 2.39%2.07B | 1.99%2.03B | 1.99%2.03B | 1.91%2.01B | 5.83%2.05B | -2.88%2.03B |
Total assets | 307.52%9.13B | 307.52%9.13B | 304.09%9.37B | 1.36%2.35B | 2.47%2.26B | 0.21%2.24B | 0.21%2.24B | -3.97%2.32B | -4.16%2.32B | -5.98%2.21B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 78.64%148.08M | 78.64%148.08M | 92.77%194.72M | 9.94%105.45M | -14.04%67.57M | -8.22%82.89M | -8.22%82.89M | -17.19%101.01M | -2.80%95.92M | 17.45%78.6M |
-accounts payable | 184.76%107.06M | 184.76%107.06M | 114.36%120.35M | 6.04%84.13M | -20.17%52.85M | -31.62%37.6M | -31.62%37.6M | -11.26%56.15M | -1.99%79.34M | 14.45%66.2M |
-Total tax payable | -9.44%41.02M | -9.44%41.02M | 65.75%74.37M | 28.59%21.32M | 18.66%14.72M | 28.21%45.3M | 28.21%45.3M | -23.58%44.87M | -6.50%16.58M | 36.56%12.41M |
Current accrued expenses | 117.96%229.64M | 117.96%229.64M | 115.48%280.33M | 15.96%114.58M | -3.16%103.62M | -9.31%105.36M | -9.31%105.36M | -8.01%130.09M | 12.14%98.82M | 16.71%107M |
Current provisions | 18.99%36.63M | 18.99%36.63M | 327.13%124.62M | 1.19%28.04M | 0.02%27.39M | 10.87%30.78M | 10.87%30.78M | 7.58%29.18M | 12.35%27.71M | 12.84%27.38M |
Current debt and capital lease obligation | --210M | --210M | --210M | --10M | ---- | ---- | ---- | ---- | ---- | ---- |
-Current debt | --210M | --210M | --210M | --10M | ---- | ---- | ---- | ---- | ---- | ---- |
Current deferred liabilities | 64.59%302.33M | 64.59%302.33M | 77.76%330.95M | 2.94%281.8M | 13.68%225.69M | 12.89%183.69M | 12.89%183.69M | 8.93%186.18M | -8.12%273.74M | -11.45%198.53M |
Current liabilities | 130.10%926.68M | 130.10%926.68M | 155.48%1.14B | 8.80%539.87M | 3.10%424.27M | 1.45%402.73M | 1.45%402.73M | -3.25%446.46M | -2.59%496.18M | 1.09%411.52M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | 111.02%4.95B | 111.02%4.95B | 104.92%4.81B | -3.58%2.42B | -0.52%2.5B | -0.11%2.35B | -0.11%2.35B | -0.10%2.35B | -2.16%2.51B | -5.37%2.52B |
-Long term debt | 107.57%4.72B | 107.57%4.72B | 101.26%4.57B | -3.25%2.35B | -0.10%2.44B | 0.32%2.28B | 0.32%2.28B | 0.33%2.27B | -4.65%2.43B | -7.89%2.44B |
-Long term capital lease obligation | 220.28%230.44M | 220.28%230.44M | 215.93%236.81M | -13.91%66.87M | -13.43%68.63M | -11.99%71.95M | -11.99%71.95M | -11.55%74.96M | 433.95%77.68M | 496.53%79.27M |
Non current deferred liabilities | 755.77%542.58M | 755.77%542.58M | 619.83%476.29M | -2.18%65.38M | -9.13%56.96M | -8.66%63.4M | -8.66%63.4M | 19.13%66.17M | 6.17%66.84M | 16.92%62.68M |
Derivative product liabilities | --290.39M | --290.39M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | --0 |
Other non current liabilities | 1,241.55%133.67M | 1,241.55%133.67M | 125.53%53.74M | -16.61%9M | -16.40%9.39M | -11.06%9.96M | -11.06%9.96M | 32.15%23.83M | 9.56%10.79M | 2.77%11.24M |
Total non current liabilities | 144.56%5.92B | 144.56%5.92B | 119.10%5.34B | -3.60%2.49B | -0.79%2.57B | -0.40%2.42B | -0.40%2.42B | 0.58%2.44B | -1.92%2.58B | -5.10%2.59B |
Total liabilities | 142.50%6.85B | 142.50%6.85B | 124.73%6.48B | -1.60%3.03B | -0.26%3B | -0.14%2.82B | -0.14%2.82B | -0.03%2.88B | -2.03%3.08B | -4.30%3B |
Shareholders'equity | ||||||||||
Share capital | --1M | --1M | --1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-common stock | --1M | --1M | --1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Retained earnings | ---164.27M | ---164.27M | --110.97M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Paid-in capital | --2.21B | --2.21B | --2.22B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Gains losses not affecting retained earnings | -115.51%-2.28M | -115.51%-2.28M | -7.05%13.96M | 1.72%14.69M | -10.27%15.01M | -5.82%14.7M | -5.82%14.7M | -8.70%15.02M | -1.22%14.44M | 41.84%16.73M |
Total stockholders'equity | --2.04B | --2.04B | --2.34B | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Noncontrolling interests | --241.82M | --241.82M | --545.69M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Total equity | 491.74%2.28B | 491.74%2.28B | 610.33%2.89B | 10.57%-682.08M | 7.86%-730.92M | 1.46%-582.96M | 1.46%-582.96M | -20.18%-565.77M | -5.08%-762.66M | -0.72%-793.24M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |